Auditor, Baby Boy .
HRN: 27-84-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/29/2025
10/06/2025
IV
45mg
Q24H
PSNB
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes